Wound healing material and preparation method thereof

By optimizing the ratio of alginate, gluconolactone, boron-containing bioactive glass and tannin in wound healing materials, the tannin modified bioactive glass hydrogel was formed, and the existing materials were solved in stopping hemostatic The problem of insufficient antibacterial, anti-inflammatory and anti-reactive oxygen performance has achieved rapid and safe healing effect on wounds.

CN118987333APending Publication Date: 2024-11-22CIXI PEOPLES HOSPITAL MEDICAL HEALTH GRP (CIXI PEOPLES HOSPITAL) +2
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202411036956.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

During the use of existing wound healing materials, there are insufficient hemostatic, anti-inflammatory, antibacterial and anti-reactive oxygen species, and the direct use of bioactive glass in wounds will lead to high pH and hemolysis, affecting the healing effect.

Method used

Using tannin modified bioactive glass hydrogel, by optimizing the mass ratio of alginate, gluconolactone, boron-containing bioactive glass and tannin, it forms good hemostatic, antibacterial, anti-inflammatory, and anti-reactive oxygen species. The performance wound healing material uses the hemostasis of alginate, the pro-angiogenesis of boron-containing glass and the antibacterial effect of tannin, and combines gluconolactone to form a weak acid environment to improve the mechanical properties and biocompatibility of the material.

Benefits of technology

It realizes excellent hemostasis, antibacterial, anti-inflammatory and anti-reactive oxygen performance of wound healing materials throughout the process, shortens the wound healing time, improves the mechanical properties and biocompatibility of the materials, and avoids the skin caused by increased pH. Inflammation ensures rapid and safe healing of wounds.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118987333A_ABST
    Figure CN118987333A_ABST
Patent Text Reader

Abstract

The invention provides a wound healing material and a preparation method thereof, and relates to the technical field of biomedical materials. The main component of the wound healing material provided by the invention is tannic acid modified bioactive glass hydrogel, and the raw materials of the tannic acid modified bioactive glass hydrogel comprise alginate, glucolactone, boron-containing bioactive glass, tannic acid and water. The wound healing material provided by the invention has good anti-hemolytic performance, anti-inflammatory performance and mechanical performance, can fully participate in the whole process of wound healing, and also has excellent antibacterial performance, anti-active oxygen performance, hemostatic performance and vascularization promoting performance; tissue regeneration and repair are promoted through hemostasis, anti-inflammation, migration and proliferation of cells, decomposition of III-type collagen and synthesis of I-type collagen. The problems that an existing bioactive glass-loaded wound dressing is poor in anti-hemolytic performance and mechanical performance, prone to causing wound inflammation and difficult to participate in the whole process of wound healing are solved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of biomedical materials, and in particular to a wound healing material and a preparation method thereof. Background Art

[0002] As the largest organ in the human body, the skin has limited resistance to serious skin diseases, such as burns, trauma and chronic ulcers, which can damage the skin's anatomical structure and function. Existing types of wound dressings include Band-Aids, gauze, hydrocolloid dressings, etc. Band-Aids and gauze are the most commonly used wound covering materials in daily life. They can exert compression hemostasis and protect the wound surface, but they also have some disadvantages and limitations. For example, gauze must be replaced frequently, and adhesion to the wound during replacement can cause secondary damage or even wound infection. Hydrogel dressings are gradually being used in clinical practice. Due to their high water content, they can show better potential in wound healing assistance, chronic wound treatment and surgical hemostasis.

[0003] Wound healing is a long and slow process, which can generally be divided into the hemostasis stage, inflammation stage, proliferation stage and remodeling stage. The ionic dissolution products of bioactive glass play a positive role in all stages of wound healing. In the hemostasis stage, bioactive glass promotes wound hemostasis by releasing calcium ions and cooperating with thrombin; in the inflammation stage, bioactive glass releases alkaline ions to neutralize acidic secretions and remove bacteria and dead cells; in the proliferation stage. Bioactive glass can promote the main processes of migration and proliferation of key cells including keratinocytes, fibroblasts and endothelial cells, such as re-epithelialization, angiogenesis and granulation tissue formation. In the remodeling stage, bioactive glass promotes the reorganization of the extracellular matrix by promoting the decomposition of type III collagen and the synthesis of type I collagen, restoring the integrity and tensile strength of natural skin. Therefore, bioactive glass is widely used in wound healing materials, but the direct use of bioactive glass in wounds will cause the pH of the wound to be high, causing pain to patients; secondly, pure bioactive glass has hemolysis and poor biocompatibility with blood cells. In order for the hydrogel dressing to act on the wound for a long time and promote rapid wound healing, the bioactive glass hydrogel dressing is also required to have certain mechanical properties and anti-inflammatory properties, and have good hemostatic properties, anti-hemolytic properties, antibacterial properties, and anti-active oxygen properties, so that it can fully participate in the entire process of wound healing. Summary of the invention

[0004] In view of the problems existing in the prior art, the present invention provides a wound healing material and a preparation method thereof. The wound healing material has good anti-hemolytic properties, mechanical properties, and anti-inflammatory properties, and can fully participate in the entire process of wound healing. It also has excellent antibacterial properties, anti-active oxygen properties, hemostatic properties and pro-angiogenic properties, and promotes tissue regeneration and repair through hemostasis, anti-inflammation, cell migration and proliferation, decomposition of type III collagen and synthesis of type I collagen.

[0005] The invention provides a wound healing material, the main component of which is a tannic acid modified bioactive glass hydrogel. The raw materials of the tannic acid modified bioactive glass hydrogel include alginate, gluconolactone, boron-containing bioactive glass, tannic acid and water. The mass ratio of the alginate, gluconolactone and boron-containing bioactive glass is 2:(2-5):1.

[0006] The wound healing material provided by the present invention optimizes the composition of raw materials, gives full play to the performance advantages of each raw material itself, and promotes rapid wound healing; and optimizes the ratio of raw materials, and alginate, gluconolactone, boron-containing bioactive glass and tannic acid cooperate with each other to overcome the problems caused by the addition of each raw material. The good hemostatic effect of alginate, the good angiogenesis-promoting effect of boron-containing bioactive glass, the antibacterial effect of tannic acid and the weak acid environment formed by gluconolactone are utilized to make the wound healing material have good hemostatic, antibacterial, anti-inflammatory, anti-active oxygen and wound healing properties. The boron-containing bioactive glass and tannic acid are continuously released, so that the wound healing material can participate in the wound healing process for a long time; tannic acid is used to increase the cross-linking density of the hydrogel, induce strong interactions between polymers in the hydrogel, and improve the stability of the internal structure of the hydrogel. While improving the mechanical properties of the hydrogel and increasing the hemostatic effect, it also overcomes the problem of skin wound inflammation caused by the reduction of the pH value on the surface of the material due to excessive addition of tannic acid; boron-containing bioactive glass is also used to stimulate angiogenesis and promote RNA synthesis of fibroblasts, thereby promoting wound healing. Compared with bioactive glass without boron, the use of boron-containing bioactive glass is conducive to shortening the wound healing time.

[0007] In a possible embodiment, the raw materials for synthesizing the tannic acid-modified bioactive glass hydrogel further include a calcium salt. Preferably, the calcium salt is selected from any one of calcium chloride, calcium lactate, calcium hydrogen phosphate and calcium gluconate.

[0008] In a possible embodiment, in the synthetic raw materials of the tannic acid modified bioactive glass hydrogel, the mass ratio of alginate, gluconolactone, and boron-containing bioactive glass is 2: (2-3): 1. By controlling the mass ratio of alginate, gluconolactone, and boron-containing bioactive glass to 2: (2-3): 1, the wound healing material can have better mechanical properties and promote wound healing more quickly.

[0009] In a possible implementation, the alginate is sodium alginate or potassium alginate.

[0010] In a possible embodiment, the boron-containing bioactive glass comprises the following raw materials by weight: 250-550 parts of silicon dioxide, 180-300 parts of boron oxide, 98-120 parts of sodium bicarbonate, 350-450 parts of calcium oxide, 35-85 parts of calcium phosphate, 95-135 parts of magnesium carbonate and 120-200 parts of potassium carbonate. The boron-containing bioactive glass with the above optimized ratio can release calcium ions, silicon ions, phosphate ions and borate ions, which can accelerate wound healing and improve the mechanical properties of wound healing materials.

[0011] The present invention also provides a method for preparing the above-mentioned wound healing material, which comprises the following steps:

[0012] S1, the alginate aqueous solution is mixed with gluconolactone and then mixed with the boron-containing bioactive glass through a three-way valve to form a bioactive glass hydrogel;

[0013] S2. The bioactive glass hydrogel is immersed in a calcium salt solution and a tannic acid solution respectively to obtain a tannic acid-modified bioactive glass hydrogel wound healing material.

[0014] The preparation method of the wound healing material provided by the present invention uses a three-way valve for mixing, so that alginate and bioactive glass are mixed more evenly, thereby overcoming the problem that the alginate and bioactive glass are not mixed evenly due to the use of mechanical stirring alone, resulting in a prolonged gelation time of the hydrogel and the easy flow of the formed hydrogel.

[0015] In a possible implementation, in step S1, the concentration of the alginate aqueous solution is 1-4%, preferably 2%.

[0016] In a possible implementation, in step S2, the concentration of the calcium salt solution is 0.01-0.1 g / mL, preferably 0.06 g / mL.

[0017] In a possible implementation, in step S2, the concentration of tannic acid in the tannic acid solution is 0.05 g / mL-0.2 g / mL, preferably 0.1 g / mL. By further controlling the concentration of tannic acid, while effectively improving the mechanical properties and anti-inflammatory properties of the wound healing material, it is also possible to better avoid the occurrence of skin wound inflammation caused by excessively high concentrations of tannic acid and direct contact with the skin.

[0018] In a possible implementation, in step S2, the solvent of the calcium salt solution and the tannic acid solution is water.

[0019] In a possible embodiment, the method of soaking the bioactive glass hydrogel in the calcium salt solution and the tannic acid solution respectively is: the bioactive glass hydrogel is soaked in the calcium salt solution for the first time and then in the tannic acid solution. The wound healing material prepared by the preparation method of the wound healing material mentioned above comprises sodium alginate, gluconolactone, boron-containing bioactive glass and tannic acid (recorded as SA / BG-TA). Through the mutual cooperation between sodium alginate, boron-containing bioactive glass and tannic acid, the wound healing material has good hemostatic, antibacterial, anti-inflammatory, anti-active oxygen and promotion of wound tissue regeneration and repair performance, and can participate in the wound healing process for a long time.

[0020] In a possible embodiment, in step S2, the method of soaking the bioactive glass hydrogel in the calcium salt solution and the tannic acid solution respectively is: after soaking in the calcium salt for the first time and in the tannic acid solution, soaking in the calcium salt for the second time. By soaking the bioactive glass hydrogel in the calcium chloride solution again, the calcium ions replace the sodium ions in the sodium alginate to form a cross-linked network similar to the "egg box" structure, which can bind the calcium ions to the tannic acid-modified bioactive glass hydrogel and further improve the comprehensive performance of the wound healing material.

[0021] The wound healing material prepared by the above-mentioned wound healing material preparation method comprises sodium alginate, gluconolactone, boron-containing bioactive glass, tannic acid and calcium ions (denoted as SA / BG-TA / Ca 2+ ). In the wound healing material, sodium alginate, gluconolactone, boron-containing bioactive glass, tannic acid and calcium ions cooperate with each other to further improve the various performances of the wound healing material.

[0022] In a possible implementation, in step S2, the bioactive glass hydrogel is immersed in the tannic acid solution for 1-1.5 hours.

[0023] In a possible implementation, in step S2, the initial soaking time is 10-40 seconds, preferably 30 seconds.

[0024] In a possible implementation manner, the secondary immersion time is 15-40 minutes.

[0025] The reagents and raw materials used in the present invention are commercially available.

[0026] The positive and progressive effects of the present invention are:

[0027] The invention provides a preparation method of a wound healing material, wherein the raw materials are cheap and readily available, green and environmentally friendly, mainly using raw materials from natural plants, mild reaction conditions, a hydrogen bond cross-linking method, a simple preparation process, and is conducive to mass production.

[0028] The wound healing material provided by the present invention uses gluconolactone to provide a weak acid environment, helps calcium ions to be released from bioactive glass, reduces the use concentration of tannic acid components, shortens the gelling time, has excellent hemostatic effect, anti-hemolytic performance and antibacterial performance, can quickly remove active oxygen, and also has good biocompatibility, can reduce inflammation, and promote the performance of wound tissue regeneration and repair. The material realizes the slow release of boron-containing bioactive glass, tannic acid and calcium ions, so that each component participates in the wound healing process for a long time, which is conducive to rapid wound healing. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 The wound healing material (SA / BG-TA / Ca 2+ ) and the hydrogel state diagram of the wound healing material (SA / BG) prepared in Comparative Example 1.

[0030] Figure 2 The wound healing material (SA / BG-TA / Ca 2+ ) and the strain diagram of the wound healing material (SA / BG) prepared in Comparative Example 1.

[0031] Figure 3 Sodium alginate (SA), tannic acid (TA), boron-containing bioactive glass (BG), the wound healing material (SA / BG-TA) prepared in Example 1, the wound healing material SA / BG-TA / Ca prepared in Example 2 2+ And the infrared absorption spectrum of the bioactive glass hydrogel (SA / BG) prepared in Comparative Example 1.

[0032] Figure 4 This is a scanning electron microscope (SEM) image of the bioactive glass hydrogel (SA / BG) prepared in Comparative Example 1.

[0033] Figure 5This is a scanning electron microscope (SEM) image of the wound healing material (SA / BG-TA) prepared in Example 1.

[0034] Figure 6 The wound healing material (SA / BG-TA / Ca 2+ ) of the scanning electron microscope (SEM).

[0035] Figure 7 The graph is a test result of the survival rate of human umbilical vein endothelial cells (HUVEC) and mouse embryonic fibroblasts (3T3) in the cytotoxicity test of the materials prepared in the control group, comparative example 1, example 1 and example 2, and the scale in the graph is 100um.

[0036] Figure 8 This is a graph showing the test results of the anti-active oxygen performance of materials prepared from tannic acid, comparative example 1, example 1 and example 2.

[0037] Fig. 9 The anti-hemolytic properties, hemostatic effects and data graphs of the materials prepared in the control group, tannic acid group, comparative example 1, example 1 and example 2.

[0038] Fig.10 The antibacterial effect diagram and data statistics diagram of the materials prepared in the control group, comparative example 1, embodiment 1 and embodiment 2.

[0039] Fig.11 These are graphs and data statistics of the wound healing effects of the control group, the boron-containing bioactive glass, and the materials prepared in Examples 1 and 2.

[0040] Fig.12 It is the ion release concentration data diagram of the materials prepared in the control group, comparative example 1, example 1 and example 2.

[0041] Fig.13 This is the shear thinning property of the wound healing material prepared in Example 2, i.e., the injectability rheological test diagram.

[0042] Fig.14 HE staining of the skin tissue of the control group, the boron-containing bioactive glass, and the materials prepared in Example 1 and Example 2 after being used by modeling mice for 14 days.

[0043] Fig.15 This is the immunostaining picture of the skin tissue of the control group, the boron-containing bioactive glass, and the materials prepared in Example 1 and Example 2 after being used by modeling mice for 7 days. The scale in the picture is 20um.

[0044] Fig.16 This is a state diagram of the wound healing material (SA / BG) hydrogel prepared in Comparative Example 1, Comparative Example 2, and Example 3.

[0045] Fig.17 The wound healing material (SA / BG-TA) prepared in Example 4 and the wound healing material (SA / BG-TA / Ca 2+ ) on promoting the healing of inflammatory wounds in mice.

[0046] Fig.18 This is a diagram of the hydrogel state of the wound healing material (SA / BG) prepared in Comparative Example 3. DETAILED DESCRIPTION

[0047] In order to make the above-mentioned purposes, features and advantages of the present invention more obvious and easy to understand, the specific embodiments of the present invention are described in detail below. It should be noted that the following embodiments are only used to illustrate the implementation method and typical parameters of the present invention, and are not used to limit the parameter range described in the present invention. Reasonable changes derived therefrom are still within the scope of protection of the claims of the present invention.

[0048] It should be noted that the endpoints and any values ​​of the ranges disclosed in this article are not limited to the precise ranges or values, and these ranges or values ​​should be understood to include values ​​close to these ranges or values. For numerical ranges, the endpoint values ​​of each range, the endpoint values ​​of each range and the individual point values, and the individual point values ​​can be combined with each other to obtain one or more new numerical ranges, and these numerical ranges should be regarded as specifically disclosed in this article.

[0049] Unless otherwise defined, all terms, symbols and other scientific terms used herein are intended to have the same meaning as those commonly understood by those skilled in the art to which the present invention belongs. In some cases, terms with conventionally understood meanings are defined herein for the purpose of clarification or ease of reference, and such definitions herein should not be construed as indicating significant differences from conventional understandings in the art. The technical methods described or cited herein are generally well understood by those skilled in the art and are adopted by conventional methods. Unless otherwise stated, the use of commercially available kits, reagents and instruments is carried out in accordance with the protocols and parameters given by the manufacturer.

[0050] Example 1

[0051] This embodiment provides a wound healing material (SA / BG-TA), which is prepared by the following preparation method:

[0052] 1) Dissolve 1g of sodium alginate powder in 50mL of deionized water and stir with a magnetic stirrer at room temperature until the powder is completely dissolved to obtain a 2% sodium alginate solution;

[0053] 2) Use a syringe to draw 1 mL of the sodium alginate solution prepared in step 1) and add it to the EP tube containing 30 mg of gluconolactone. After the gluconolactone is dissolved by the sodium alginate solution, mix it evenly in a three-way valve to form a precursor solution;

[0054] 3) The precursor solution obtained in step 2) and 10 mg of boron-containing bioactive glass powder were first mixed in an EP tube, then transferred to a syringe, and the three-way valve was used to repeatedly pipette between the two syringes 20 to 30 times until the solution was mixed evenly. After standing for one minute, a bioactive glass hydrogel was formed;

[0055] 4) The bioactive glass hydrogel prepared in step 3) was soaked in a 0.06 g / mL calcium chloride solution for 30 seconds. After a protective film was formed on the surface, the calcium chloride solution was removed and the hydrogel was soaked in a 0.1 g / mL tannic acid solution for 1 hour. After the tannic acid and the hydrogel were fully in contact, the tannic acid solution was removed to obtain a tannic acid-modified bioglass hydrogel (SA / BG-TA).

[0056] Example 2

[0057] The difference between Example 2 and Example 1 is that step 4) is: the bioactive glass hydrogel prepared in step 3) is soaked in 0.06 g / mL calcium chloride solution for 30 seconds, after a protective film is formed on the surface, the calcium chloride solution is removed, and the bioactive glass hydrogel is soaked in 0.1 g / mL tannic acid solution for 1 hour, after the tannic acid and the hydrogel are fully in contact, the tannic acid solution is removed, and the bioactive glass hydrogel (SA / BG-TA / Ca) is obtained by soaking in 0.06 g / mL calcium chloride solution for 30 minutes. 2+ ).

[0058] Example 3

[0059] The difference between Example 3 and Example 1 is that the amount of gluconolactone used in step 2) is 40 mg.

[0060] Example 4

[0061] The difference between Example 4 and Example 1 is that in step 4), the concentration of the tannic acid solution is 0.2 g / mL, and the concentration of calcium chloride is 0.06 g / mL.

[0062] Comparative Example 1

[0063] The difference between this comparative example and Example 1 is that step 4) is not included, and the obtained product is a bioactive glass hydrogel (SA / BG).

[0064] Comparative Example 2

[0065] The difference between Comparative Example 2 and Example 1 is that the amount of gluconolactone used in step 2) is 10 mg.

[0066] Comparative Example 3

[0067] The difference between Comparative Example 3 and Example 1 is that in step 2) and step 3), a three-way valve is not used for mixing, but a magnetic stirrer is used for stirring and mixing.

[0068] Test results

[0069] Figure 1 The wound healing material (SA / BG-TA / Ca 2+ ) and the hydrogel state diagram of the bioactive glass hydrogel (SA / BG) prepared in Comparative Example 1. Compared with SA / BG hydrogel, SA / BG-TA / Ca 2+ Hydrogels are easier to shape, do not flow when the vial is tilted, have better mechanical properties, and are more suitable as wound dressings.

[0070] Figure 2 The wound healing material (SA / BG-TA / Ca 2+ ) and the wound healing material (SA / BG) prepared in comparative example 1. The dynamic rheological behavior of the hydrogel was evaluated using a rotational rheometer. The hydrogel was placed in the operating stage and the gap was set to 1.5 mm at 25°C. In order to determine the linear viscoelastic region of the hydrogel, a strain amplitude scan from 0.01 to 1000% was performed at 1 Hz. Figure 2 It can be seen that after the introduction of tannic acid, the internal structure of the hydrogel became more stable, and a gel-sol transition occurred at the junction of the storage modulus (G′) and loss modulus (G″) curves. Compared with SA / BG hydrogel, SA / BG-TA / Ca 2+ The gel-sol transition point of the hydrogel requires a larger force to change, indicating that SA / BG-TA / Ca 2+ The hydrogels have good mechanical properties, which may be because the addition of TA increases the cross-linking density of the hydrogels and induces strong interactions between polymers.

[0071] Figure 3 Sodium alginate (SA), tannic acid (TA), boron-containing bioactive glass (BG), the wound healing material prepared in Example 1 (SA / BG-TA), the wound healing material prepared in Example 2 (SA / BG-TA / Ca 2+) and the infrared absorption spectra of the bioactive glass hydrogel (SA / BG) prepared in Example 1. The chemical structure and interaction of the hydrogel were characterized by FTIR. Fourier transform infrared spectroscopy (FTIR, Bruker Alpha, Germany) was used at 4000-500 cm -1 The molecular structure and chemical bonds of the designed hydrogels were analyzed within a wide range. Figure 3 It can be seen that the -COOH peak of SA / BG is at 1602 cm -1 (symmetric-COO-stretching vibration) and 1442 cm -1 (asymmetric-COO-stretching vibration), which is shifted compared to the SA peak. The band shift can be attributed to the recombination between BG and SA. 3326cm -1 It is caused by the vibration of hydroxyl and amine groups in sodium alginate. This peak also appears in SA / BG hydrogel. -1 The TA spectrum peaks at 10 and 11 are attributed to the C—O, C—C and C—H stretching vibrations of the substituted benzene rings, which also appear in SA / BG-TA / Ca 2+ The hydrogels were detected at 1641, 1523 and 946 cm -1 These results indicate that TA was successfully introduced into SA / BG, making the internal structure of the hydrogel more stable and improving the mechanical properties of the wound healing material.

[0072] Figure 4 This is a scanning electron microscope (SEM) image of the bioactive glass hydrogel (SA / BG) prepared in Comparative Example 1. Figure 5 This is a scanning electron microscope (SEM) image of the wound healing material (SA / BG-TA) prepared in Example 1. Figure 6 The wound healing material (SA / BG-TA / Ca 2+ ). After the hydrogel is placed in a six-well plate to form a gel, it is sealed with a sealing film. The six-well plate is placed in a -80°C refrigerator for 30 minutes, and then the culture dish is moved into a pre-cooled freeze dryer again. It is freeze-dried in a vacuum environment for 12 hours. After the liquid in the hydrogel is completely sublimated, the culture dish is taken out to obtain the freeze-dried hydrogel scaffold. After the hydrogel scaffold is cut into thin slices with a blade, it is sprayed with gold in a vacuum for 1 minute. The gold-sprayed hydrogel slices are then moved into the SEM operating table. After the SEM operating room is in a vacuum state, the surface microstructure of the hydrogel scaffold is observed at different magnifications. Figure 4 , Figure 5 and Figure 6It can be seen that the hydrogel scaffolds formed after freeze-drying of the wound healing material (SA / BG-TA) prepared in Example 1 and the bioactive glass hydrogel (SA / BG) prepared in Comparative Example 1 both have smooth surfaces and interconnected porous structures under the SEM field of view, while the pores of the wound healing materials prepared in Examples 1 and 2 are significantly reduced due to the hydrogen bonding effect after the addition of tannic acid. In Example 2, calcium ions contact and react with hydroxyl ions in the hydrogel to form calcium salt crystals, so there are crystals on the surface under the SEM field of view.

[0073] Figure 7 The figure is a schematic diagram of the survival rate of human umbilical vein endothelial cells (HUVEC) and mouse embryonic fibroblasts (3T3) in the cytotoxicity test of the wound healing materials prepared by the control group, comparative example 1, example 1 and example 2. Human umbilical vein endothelial cells (HUVEC) and mouse embryonic fibroblasts (3T3) were used to test the cytotoxicity of the hydrogel. 3 The hydrogel was placed in a cell culture dish with a diameter of 6 cm. After irradiation with UV light for one hour, 10 mL of high glucose culture medium was added to the culture dish, and the culture dish was placed in a cell culture incubator for 24 hours. After incubation, the solution was removed from the culture dish, centrifuged at 1000 rpm to remove the hydrogel fragments, and filtered with a 0.22 μm filter. The solution was used as a hydrogel extract and stored at 4°C for future use. The CCK-8 kit was used for cell counting to evaluate the biocompatibility of the hydrogel extract. The original hydrogel extract was diluted with high glucose culture medium at a ratio of 1 / 16. Then SA / BG, SA / BG-TA, SA / BG-TA / Ca 2+ Cells were cultured with hydrogel extract, and cells cultured with normal culture medium were used as control (Control). HUVEC or 3T3 cells were seeded in a 96-well plate at a density of 5000 cells per well, cultured with normal culture medium for 12 hours, and then the cell culture medium was discarded. 100ul / well of new culture medium was added to the control group, and 100ul / well of different hydrogel extracts were added to each drug-treated group. After incubation for 24, 48, and 72 hours, the culture medium was aspirated, and 100μl of serum-free culture medium containing 10% CCK-8 solution was added to each well. The OD value at 450nm was measured with an enzyme reader. At the same time, the calcineurin (AM) / propidium iodide (PI) double staining method was used to detect cell biocompatibility, and the cells were observed using a fluorescence microscope. The results are shown in Figure 6 As shown in the figure, the scale is 100um. After 1, 2, and 3 days of culture with hydrogel extract, the activity of HUVEC cells and 3T3 cells in each hydrogel extract intervention group was above 70%, which meets the international biomaterial standard (ISO10993:2009). In addition, bright green fluorescence specific labeling of living cells was observed in all hydrogel groups, indicating that the prepared hydrogels have good in vitro biocompatibility.

[0074] Figure 8 The figure is a test result of the anti-active oxygen performance of the materials prepared by tannic acid, comparative example 1, example 1 and example 2. 50 mg of hydrogel was placed in a 0.1 mM 1,1-diphenyl-2-trinitrophenylhydrazine solution (DPPH), incubated for half an hour in the dark, and the solution was taken out to a 96-well plate at 10 minutes, 20 minutes and 30 minutes, and the absorbance was tested at 517 nm using an ELISA instrument. The free radical scavenging rate = (A0-A1) / A0*100% (A0 is the absorbance of the DPPH solution before the reaction, and A1 is the absorbance of the DPPH solution after the reaction). Figure 8 The left picture shows the color of the solution after incubation for 30 minutes. 2+ The clearance rate of the hydrogel group was higher than that of the control group and the SA / BG hydrogel group, indicating that it had better anti-ROS performance. The ROS scavenging effect may come from tannic acid.

[0075] Fig. 9 The anti-hemolytic performance, hemostatic effect and data graphs of the materials obtained from the control group, tannic acid group, comparative example 1, example 1 and example 2. In the anti-hemolytic performance experiment, the control group included Triton X, PBS, boron-containing bioactive glass and tannic acid. 10 mg of boron-containing bioactive glass / tannic acid / hydrogel lyophilized powder was dissolved in 1 mL of phosphate buffered saline (PBS), and 500 μL of diluted red blood cells (4% PBS) were added to a centrifuge tube. 1 mL of 0.1% Triton X and 1 mL of phosphate buffered saline (PBS) were used as positive and negative controls. After incubation at 37°C for 3 hours, centrifugation was performed at 3500 rpm for 10 minutes. Finally, the optical density (OD) of the supernatant at 540 nm was calculated. The hemolysis rate calculation formula is as follows: Hemolysis rate = (OD 样品 -OD 阴性对照 ) / (OD 阳性对照 -OD 阴性对照 )*100%. The supernatant of each hydrogel group was clear and transparent, and the hemolysis rate was less than 5%, which met the international biomaterial standard (ISO10993:2009). The rat liver bleeding model was used to evaluate the in vivo hemostatic effect of the hydrogel. First, the rat was anesthetized with a 10% chloral hydrate PBS solution. Then a 20G 0.6mm needle was used to scratch and cause bleeding, and then a pre-weighed filter paper was placed under the liver. The hydrogel was then quickly applied to the bleeding site, and the paper was weighed after 2 minutes to determine the amount of bleeding. The control group (Control) was not used for hydrogel coating. The results showed that the amount of bleeding in each hydrogel group was much less than that in the control group, among which the hydrogel prepared in Example 2 had the best hemostatic effect.

[0076] Fig.10The antibacterial effect diagram of the materials prepared in the control group, comparative example 1, example 1 and example 2. 100 mg of sterile hydrogel was placed in a 12-well plate and mixed with 1 mL of 1×10 6 CFU / mL of Staphylococcus aureus suspension or Escherichia coli suspension was mixed. After incubation at 37℃ for 12h. Subsequently, 100μL of the diluted culture medium was applied to plate count agar, incubated at 37℃ for 12h, and the colonies were counted. Staphylococcus aureus and Escherichia coli suspensions were used as controls (Control). After 12h of hydrogel treatment, there were almost no Staphylococcus aureus colonies on the agar plate in the hydrogel group, and the antibacterial rate was as high as 99%. SA / BG-TA and SA / BG-TA / Ca 2+ The inhibitory effect on Escherichia coli is higher than that of the SA / BG group. This is mainly due to the continuous release of TA in the hydrogel. The antibacterial effect of TA may be related to its ability to destroy and inhibit the formation of bacterial membranes. The hydrogels prepared in Example 1 and Example 2 both showed excellent antibacterial ability. In the inhibition zone test, Escherichia coli and Staphylococcus aureus were cultured overnight in LB medium at 37°C with shaking (200rpm). 100 μL of bacterial dilution was evenly distributed on the agar plate. 100 mg of freshly prepared hydrogel of the same size and shape was exposed to ultraviolet light for 1 hour for sterilization, and the hydrogel samples prepared in Example 1, Example 2 and Comparative Example 1 were placed on LB agar plates. After incubation at 37°C for 24 hours, the diameter of the inhibition zone was measured. The average diameter of the inhibition zone in the SA / BG-TA hydrogel Escherichia coli nutrient agar plate was 1.25 cm, and the average diameter of the inhibition zone in the Staphylococcus aureus nutrient agar plate was 1.75 cm, and the average diameter of the inhibition zone in the SA / BG-TA / Ca 2+ The average diameter of the antibacterial zone of the hydrogel in the Escherichia coli culture agar plate is about 1 cm, and the average diameter of the antibacterial zone in the Staphylococcus aureus culture agar plate is about 1.4 cm. These results show that compared with the hydrogel prepared in Comparative Example 1, the hydrogels prepared in Example 1 and Example 2 have significant antibacterial effects on Escherichia coli and Staphylococcus aureus, and the antibacterial activity against Staphylococcus aureus is stronger than that against Escherichia coli, and the antibacterial effect of SA / BG-TA is stronger than that of SA / BG-TA / Ca 2+ Hydrogel, it may be that tannic acid plays the main antibacterial role in the hydrogel. Continuing to wrap a layer of calcium chloride on the surface will affect the release of tannic acid and slightly reduce the antibacterial effect.

[0077] Fig.11The figures show the effects of promoting wound healing of the control group, boron-containing bioactive glass, and the materials prepared in Examples 1 and 2. In order to evaluate the wound healing ability of the hydrogel in vivo, an animal model of full-thickness skin defect was established using ICR mice. All animal operations were carried out in accordance with the "Guidelines for the Care and Use of Laboratory Animals of Wenzhou Medical University", and the experiments were approved by the Animal Ethics Committee of Wenzhou Medical University (Ethical Standards: YSG24030103). Male ICR mice (8 weeks, 25 g) were first anesthetized with 4% chloral hydrate, and then a full-thickness circular piece of skin with a diameter of 6 mm was cut off from the back of each mouse with forceps and scissors. On the first day, physiological saline, bioactive glass, the hydrogel prepared in Example 1 (SA / BG-TA) or the hydrogel prepared in Example 2 (SA / BG-TA / Ca 2+ ) was used to treat the wound. On the 14th day, the mice were killed and dorsal skin sections were taken for histological study. The wounds not treated with hydrogel were used as the control group (Control). The wound closure area was measured using image J software. The wound healing rate was calculated as follows: Wound healing rate (%) = (S0-S t ) / S0×100%, where S0 is the wound area on the first day, S t To select the wound area on the day. On the 7th day, SA / BG-TA / Ca 2+ The hydrogel healed the fastest, which may be due to its better hemostatic activity. 2+ The wound surface treated with hydrogel was almost covered by regenerated skin, while the wound surface of other groups was not completely healed. These results show that the hydrogels of Example 1 and Example 2 have a high ability to promote wound healing.

[0078] Fig.12 The ion release data of the materials obtained in the control group, comparative example 1, example 1 and example 2 are shown in Figure 1. 1 mL of the hydrogel was soaked in a 50 mL centrifuge tube containing 10 mL of simulated body fluid, and the centrifuge tube was moved to a 37°C cell constant temperature incubator. After 24 hours, the hydrogel soaked in the centrifuge tube was taken out, and the solution was filtered with a 0.22 μm filter. The filtered solution was stored at 4°C. The concentrations of calcium, silicon and phosphorus in the obtained solution were determined by electrically coupled plasma atomic emission spectroscopy (ICP-AES). In order to clarify the content of calcium, silicon and phosphorus ions released in the hydrogel, this study also tested the calcium, silicon and phosphorus content in the simulated body fluid (without soaking in hydrogel) to eliminate the interference of the original ions in the simulated body fluid solution (Control). The experimental results show that the materials obtained in Example 1 and Example 2 can also release the same effective ions as bioactive glass, indicating that the hydrogel does not affect the ion release of bioactive glass.

[0079] Fig.13The wound healing material (SA / BG-TA) prepared in Example 1 demonstrated the shear thinning property of the hydrogel, i.e., injectability, through a shear rate scanning test. The change in viscosity at different shear rates was evaluated by shear rheology. As the shear rate increased, the viscosity of the hydrogel decreased, proving that the hydrogel is injectable.

[0080] Fig.14 HE staining of the skin tissue at the wound surface of the model mice after the materials prepared in the control group, boron-containing bioactive glass group, and Example 1 and Example 2 were applied to the wound surface for 14 days. 2+ The collagen index of the hydrogel group was significantly higher than that of the other treatment groups. The wound surface not treated with hydrogel was the control group (Control). As shown in the figure, the amount of collagen deposition in the 14-day control group was still the least among all the groups. The purple area of ​​the control group was significantly lighter than that of the other groups in the staining map, and the blank area of ​​the tissue was larger, while the SA / BG-TA / Ca 2+ The SA / BG-TA / Ca group not only has the largest collagen deposition area (the purple area is darker and the blank area is smaller in the staining image), but also has a more regular arrangement and distribution of collagen than the other groups, which is most similar to the collagen arrangement structure in normal skin tissue. 2+ Hydrogel can promote the deposition of collagen in wound tissue, and the promoting effect is enhanced when BG and TA are used in combination.

[0081] Fig.15 The following is an immunofluorescence staining diagram of the skin samples at the wound surface of the model mouse after the materials prepared in the control group, boron-containing bioactive glass group, Example 1 and Example 2 were applied to the wound surface of the model mouse for 7 days. The scale in the figure is 20um. CD31 and VEGF are both vascularization indicators. CD31 is an intravascular epithelial marker, and VEGF is vascular endothelial growth factor. The wound surface not treated with hydrogel is the control group (Control). Further histological studies were performed on the skin sections collected from the above animal experiments. Fresh skin tissue was fixed with 4% paraformaldehyde for 24 hours, then gradiently dehydrated with solutions of different ethanol contents and embedded in paraffin. Subsequently, the samples were cut into 5μm thick sections. Immunofluorescence staining: Skin sections were stained with CD31, α-SMA, VEGF antibodies and DAPI. α-SMA is a vascular smooth muscle protein, and DAPI is 4',6-diamidino-2-phenylindole. The immunofluorescence results showed that both BG and the hydrogel containing BG have the effect of promoting angiogenesis. The hydrogel prepared in Example 2 has the most significant effect of promoting angiogenesis. This is because the boron-containing bioactive glass used in this study has the effect of promoting angiogenesis. α-SMA is a marker for wound maturation. The results show that the hydrogel can promote wound healing.

[0082] Fig.16The hydrogel state diagrams of Comparative Example 1, Comparative Example 2, and Example 3. In Comparative Example 2, the dosage of gluconolactone was 10 mg, and it could not form gel, and it was still in a flowing state after waiting for one day. When the dosage of gluconolactone in Comparative Example 1 was 30 mg, the gelation time of the hydrogel was 4 minutes and 30 seconds. When the dosage of gluconolactone in Example 3 was 40 mg, the gelation time of the hydrogel was shortened by one minute to 3 minutes and 30 seconds, and the hydrogel state was consistent. However, gluconolactone is an acidic substance, and excessive dosage will affect the release of bioactive glass ions.

[0083] Fig.17 The wound healing material (SA / BG-TA / Ca 2+ ) and the wound healing material (SA / BG-TA) prepared in Example 4 on promoting the healing of mouse wound inflammation (all on the 4th day). The results show that too high a concentration of tannic acid and direct contact with the skin will cause an inflammatory response in mouse skin wounds. Increasing the concentration of tannic acid in Example 4 will increase the acidity of the hydrogel surface, thereby strengthening the inflammatory response of the skin wound. The role of calcium chloride is to form a protective film on the surface of SA / BG, and finally to form a protective film on the surface of SA / BG-TA. The former is to prevent too much tannic acid from entering the SA / BG hydrogel, and the acidic environment will affect the release of bioactive glass ions, while the latter is to reduce the acidity of the hydrogel surface, allowing tannic acid to be slowly released into the wound, alleviating the wound inflammation response caused by excessive release of tannic acid.

[0084] Fig.18 The hydrogel state diagram of the wound healing material (SA / BG) prepared in Comparative Example 3. The gel state of the hydrogel prepared by mixing with the three-way valve in Example 2 Figure 1 In contrast, the hydrogel prepared by stirring with a magnetic stirrer has a slower gelation speed and the bioactive glass still appears in particles in the hydrogel, while mixing using a three-way valve allows the bioactive glass to be better mixed into the hydrogel, with better uniformity and faster gelation speed.

[0085] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein by equivalents. However, these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the scope of the technical solutions of the embodiments of the present invention.

Claims

1. A wound healing material, characterized in that: Its main component is tannic acid modified bioactive glass hydrogel, the synthetic raw materials of the tannic acid modified bioactive glass hydrogel include alginate, gluconolactone, boron-containing bioactive glass, tannic acid and water, and the mass ratio of alginate, gluconolactone and boron-containing bioactive glass is 2:(2-5):

1.

2. The wound healing material according to claim 1, characterized in that: The synthetic raw materials of the tannic acid-modified bioactive glass hydrogel also include calcium salt; And / or, in the synthetic raw materials of the tannic acid-modified bioactive glass hydrogel, the mass ratio of alginate, gluconolactone and boron-containing bioactive glass is 2:(2-3):

1.

3. The wound healing material according to claim 2, characterized in that: The alginate is sodium alginate or potassium alginate; And / or, the calcium salt is selected from any one of calcium chloride, calcium lactate, calcium hydrogen phosphate and calcium gluconate; And / or, the boron-containing bioactive glass comprises the following raw materials in parts by weight: 250-550 parts of silicon dioxide, 180-300 parts of boron oxide, 98-120 parts of sodium bicarbonate, 350-450 parts of calcium oxide, 35-85 parts of calcium phosphate, 95-135 parts of magnesium carbonate and 120-200 parts of potassium carbonate.

4. A method for preparing the wound healing material according to any one of claims 1 to 3, characterized in that: The following steps are involved: S1, the alginate aqueous solution is mixed with gluconolactone and then mixed with the boron-containing bioactive glass through a three-way valve to form a bioactive glass hydrogel; S2. The bioactive glass hydrogel is immersed in a calcium salt solution and a tannic acid solution respectively to obtain a tannic acid-modified bioactive glass hydrogel wound healing material.

5. The method for preparing the wound healing material according to claim 4, characterized in that: In step S1, the concentration of the alginate aqueous solution is 1-4%; And / or, in step S2, the concentration of the calcium salt solution is 0.01-0.1 g / mL; And / or, in step S2, the concentration of tannic acid in the tannic acid solution is 0.05-0.2 g / mL.

6. The method for preparing the wound healing material according to claim 4, characterized in that: In step S1, the concentration of the alginate aqueous solution is 2%; And / or, in step S2, the concentration of the calcium salt solution is 0.06 g / mL; And / or, in step S2, the concentration of tannic acid in the tannic acid solution is 0.1 g / mL.

7. The method for preparing the wound healing material according to claim 4, characterized in that: In step S2, the method of soaking the bioactive glass hydrogel in the calcium salt solution and the tannic acid solution respectively is as follows: the bioactive glass hydrogel is first soaked in the calcium salt solution and then soaked in the tannic acid solution.

8. The method for preparing the wound healing material according to claim 4, characterized in that: In step S2, the method of soaking the bioactive glass hydrogel in the calcium salt solution and the tannic acid solution respectively is: the bioactive glass hydrogel is soaked in the calcium salt solution for the first time and in the tannic acid solution, and then soaked in the calcium salt solution for the second time.

9. The method for preparing the wound healing material according to claim 7 or 8, characterized in that: The time for the bioactive glass hydrogel to be immersed in the tannic acid solution is 1-1.5 hours; And / or, the initial soaking time is 10-40s; And / or, the secondary immersion time is 15-40 minutes.

10. The method for preparing the wound healing material according to claim 9, characterized in that: The initial soaking time is 30s; And / or, the secondary immersion time is 30 minutes.

Citation Information

Cited By

  • Gel and preparation method thereof

    CN119454582A